基于PREVAL研究队列验证机器学习模型用于早孕期子痫前期预测
本研究将基于全连接神经网络、利用母体风险因素及MAP、UtA-PI、PlGF和PAPP-A的机器学习模型应用于西班牙PREVAL研究的10110例单胎妊娠,在10%筛查阳性率下早期、早产和全部子痫前期的检出率分别为84.4%、77.8%和55.7%,与FMF竞争风险模型性能相似,但需对生化检测分析仪进行调整。
要点
- 机器学习模型在10%筛查阳性率下早期子痫前期检出率为84.4%。
- 仅使用MAP、UtA-PI和PlGF三种生物标志物即可达到该性能,加入PAPP-A未显著改善检出率。
- 应用前必须对生化检测所用分析仪进行调整。
核心结论
- 基于神经网络的机器学习模型可有效进行早孕期子痫前期筛查,并可应用于不同人群。
- 但在应用前,必须对生化检测所用分析仪进行调整。
研究设计与样本
- 将基于全连接神经网络开发的机器学习模型应用于西班牙PREVAL研究中10110例单胎妊娠的数据集。
- 该模型基于母体风险因素及MAP、UtA-PI、PlGF和PAPP-A,此前已在英国孕妇队列中开发并测试。
- 通过受试者工作特征曲线下面积(AUC)和10%筛查阳性率下的检出率评估筛查性能,并与FMF竞争风险模型比较。
主要发现
- 机器学习模型在10%筛查阳性率下早期、早产和全部子痫前期的检出率分别为84.4%(95%CI,67.2-94.7%)、77.8%(95%CI,66.4-86.7%)和55.7%(95%CI,49.0-62.2%),对应AUC分别为0.920(95%CI,0.864-0.975)、0.913(95%CI,0.882-0.944)和0.846(95%CI,0.820-0.872)。
- 使用MAP、UtA-PI和PlGF三种生物标志物即可达到该性能,加入PAPP-A未显著改善检出率。
- FMF竞争风险模型在10%筛查阳性率下的检出率为:早期子痫前期82.7%(95%CI,69.6-95.8%)、早产子痫前期72.7%(95%CI,62.9-82.6%)、全部子痫前期55.1%(95%CI,48.8-61.4%)。
- 机器学习模型性能与FMF竞争风险模型相似,且无需针对人群进行特定调整。
关键数值与推荐
- 机器学习模型10%筛查阳性率下早期子痫前期检出率84.4%(95%CI,67.2-94.7%),AUC 0.920(95%CI,0.864-0.975)。
- 机器学习模型10%筛查阳性率下早产子痫前期检出率77.8%(95%CI,66.4-86.7%),AUC 0.913(95%CI,0.882-0.944)。
- 机器学习模型10%筛查阳性率下全部子痫前期检出率55.7%(95%CI,49.0-62.2%),AUC 0.846(95%CI,0.820-0.872)。
- FMF竞争风险模型10%筛查阳性率下早期子痫前期检出率82.7%(95%CI,69.6-95.8%)、早产子痫前期72.7%(95%CI,62.9-82.6%)、全部子痫前期55.1%(95%CI,48.8-61.4%)。
临床怎么用
- 机器学习模型可用于不同人群的早孕期子痫前期筛查,但应用前必须对生化检测所用分析仪进行调整。
- 使用MAP、UtA-PI和PlGF三种生物标志物即可,加入PAPP-A未显著改善检出率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Effective first-trimester screening for pre-eclampsia (PE) can be achieved using a competing-risks model that combines risk factors from the maternal history with multiples of the median (MoM) values of biomarkers. A new model using artificial intelligence through machine-learning methods has been shown to achieve similar screening performance without the need for conversion of raw data of biomarkers into MoM. This study aimed to investigate whether this model can be used across populations without specific adaptations. METHODS: Previously, a machine-learning model derived with the use of a fully connected neural network for first-trimester prediction of early (< 34 weeks), preterm (< 37 weeks) and all PE was developed and tested in a cohort of pregnant women in the UK. The model was based on maternal risk factors and mean arterial blood pressure (MAP), uterine artery pulsatility index (UtA-PI), placental growth factor (PlGF) and pregnancy-associated plasma protein-A (PAPP-A). In this study, the model was applied to a dataset of 10 110 singleton pregnancies examined in Spain who participated in the first-trimester PE validation (PREVAL) study, in which first-trimester screening for PE was carried out using the Fetal Medicine Foundation (FMF) competing-risks model. The performance of screening was assessed by examining the area under the receiver-operating-characteristics curve (AUC) and detection rate (DR) at a 10% screen-positive rate (SPR). These indices were compared with those derived from the application of the FMF competing-risks model. The performance of screening was poor if no adjustment was made for the analyzer used to measure PlGF, which was different in the UK and Spain. Therefore, adjustment for the analyzer used was performed using simple linear regression. RESULTS: The DRs at 10% SPR for early, preterm and all PE with the machine-learning model were 84.4% (95% CI, 67.2-94.7%), 77.8% (95% CI, 66.4-86.7%) and 55.7% (95% CI, 49.0-62.2%), respectively, with the corresponding AUCs of 0.920 (95% CI, 0.864-0.975), 0.913 (95% CI, 0.882-0.944) and 0.846 (95% CI, 0.820-0.872). This performance was achieved with the use of three of the biomarkers (MAP, UtA-PI and PlGF); inclusion of PAPP-A did not provide significant improvement in DR. The machine-learning model had similar performance to that achieved by the FMF competing-risks model (DR at 10% SPR, 82.7% (95% CI, 69.6-95.8%) for early PE, 72.7% (95% CI, 62.9-82.6%) for preterm PE and 55.1% (95% CI, 48.8-61.4%) for all PE) without requiring specific adaptations to the population. CONCLUSIONS: A machine-learning model for first-trimester prediction of PE based on a neural network provides effective screening for PE that can be applied in different populations. However, before doing so, it is essential to make adjustments for the analyzer used for biochemical testing. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Gil MM, Cuenca-Gómez D, Rolle V, et al. Validation of machine-learning model for first-trimester prediction of pre-eclampsia using cohort from PREVAL study. Ultrasound Obstet Gynecol. 2024. PMID: 37698356. doi:10.1002/uog.27478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。